p21-activated kinase 1: PAK'ed with potential

The p21-activated kinases (PAKs) are central players in growth factor signaling networks and morphogenetic processes that control proliferation, cell polarity, invasion and actin cytoskeleton organization. This raises the possibility that interfering with PAK activity may produce significant anti-tu...

Full description

Bibliographic Details
Main Authors: Ong, Christy C., Jubb, Adrian M., Zhou, Wei, Haverty, Peter M., Harris, Adrian L., Belvin, Marcia, Friedman, Lori S., Koeppen, Hartmut, Hoeflich, Klaus P.
Format: Online
Language:English
Published: Impact Journals LLC 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248206/
id pubmed-3248206
recordtype oai_dc
spelling pubmed-32482062012-01-18 p21-activated kinase 1: PAK'ed with potential Ong, Christy C. Jubb, Adrian M. Zhou, Wei Haverty, Peter M. Harris, Adrian L. Belvin, Marcia Friedman, Lori S. Koeppen, Hartmut Hoeflich, Klaus P. Research Perspectives The p21-activated kinases (PAKs) are central players in growth factor signaling networks and morphogenetic processes that control proliferation, cell polarity, invasion and actin cytoskeleton organization. This raises the possibility that interfering with PAK activity may produce significant anti-tumor activity. In this perspective, we summarize recent data concerning the contribution of the PAK family member, PAK1, in growth factor signaling and tumorigenesis. We further discuss mechanisms by which inhibition of PAK1 can arrest tumor growth and promote cell apoptosis, and the types of cancers in which PAK1 inhibition may hold promise. Impact Journals LLC 2011-06-07 /pmc/articles/PMC3248206/ /pubmed/21653999 Text en Copyright: © 2011 Ong et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Ong, Christy C.
Jubb, Adrian M.
Zhou, Wei
Haverty, Peter M.
Harris, Adrian L.
Belvin, Marcia
Friedman, Lori S.
Koeppen, Hartmut
Hoeflich, Klaus P.
spellingShingle Ong, Christy C.
Jubb, Adrian M.
Zhou, Wei
Haverty, Peter M.
Harris, Adrian L.
Belvin, Marcia
Friedman, Lori S.
Koeppen, Hartmut
Hoeflich, Klaus P.
p21-activated kinase 1: PAK'ed with potential
author_facet Ong, Christy C.
Jubb, Adrian M.
Zhou, Wei
Haverty, Peter M.
Harris, Adrian L.
Belvin, Marcia
Friedman, Lori S.
Koeppen, Hartmut
Hoeflich, Klaus P.
author_sort Ong, Christy C.
title p21-activated kinase 1: PAK'ed with potential
title_short p21-activated kinase 1: PAK'ed with potential
title_full p21-activated kinase 1: PAK'ed with potential
title_fullStr p21-activated kinase 1: PAK'ed with potential
title_full_unstemmed p21-activated kinase 1: PAK'ed with potential
title_sort p21-activated kinase 1: pak'ed with potential
description The p21-activated kinases (PAKs) are central players in growth factor signaling networks and morphogenetic processes that control proliferation, cell polarity, invasion and actin cytoskeleton organization. This raises the possibility that interfering with PAK activity may produce significant anti-tumor activity. In this perspective, we summarize recent data concerning the contribution of the PAK family member, PAK1, in growth factor signaling and tumorigenesis. We further discuss mechanisms by which inhibition of PAK1 can arrest tumor growth and promote cell apoptosis, and the types of cancers in which PAK1 inhibition may hold promise.
publisher Impact Journals LLC
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248206/
_version_ 1611497305923387392